Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 256 to 270 of 421 results for stroke

  1. During this appraisal it was noted that there is a need for additional research on the management of bleeds that occur while people are receiving apixaban, rivaroxaban or dabigatran etexilate, as there are no antidotes or established treatments to stop active bleeding for these agents.

    guidance details Comes from guidance Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial...

    Research recommendation
    Published
    10 August 2021

  2. Mental health of adults in contact with the criminal justice system (NG66)

    This guideline covers assessing, diagnosing and managing mental health problems in adults (aged 18 and over) who are in contact with the criminal justice system. It aims to improve mental health and wellbeing in this population by establishing principles for assessment and management, and promoting more coordinated care planning and service organisation across the criminal justice system.

    NICE guideline
    Published
    21 March 2017
    View recommendations

    Sections for NG66

  3. Endovascular stent insertion for intracranial atherosclerotic disease should only be used in the context of research. Research should clearly define patient selection and be designed to provide outcome data based on follow-up of at least 2 years.

    Evidence on its safety shows that there is a significant risk of periprocedural stroke and death. Source guidance details Comes from...

    Research recommendation
    Published
    9 June 2015

  4. Overweight and obesity management (QS212)

    This quality standard covers prevention, behavioural management, assessment, and treatment of overweight, obesity and central adiposity in children and young people aged over 2 years, and adults. This includes those with established comorbidities, and those with risk factors for other medical conditions. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    5 August 2025
    View quality statements

    Sections for QS212

  5. Impact of intensive blood pressure lowering on people who are frail: What is the efficacy and safety of intensive interventions to lower blood pressure compared with less intensive interventions for people with acute intracerebral haemorrhage who are frail at presentation?

    haemorrhage. Source guidance details Comes from guidance Stroke and transient ischaemic attack in over 16s: diagnosis and initial...

    Research recommendation
    Published
    11 May 2022

  6. Further research should include details of patient selection and report longer term outcomes.

    carotid stenosis. Short-term evidence suggests that the risk of disabling stroke is similar in people who have this procedure compared...

    Research recommendation
    Published
    11 January 2024

  7. Emergency and acute medical care in over 16s (QS174)

    This quality standard covers the organisation and delivery of emergency and acute medical care in the community and in hospital. It covers adults (16 and over) who seek, or are referred for, emergency NHS care for a suspected or confirmed acute medical emergency. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    7 September 2018
    View quality statements

    Sections for QS174

  8. Impact of intensive interventions to lower blood pressure on cognitive function, functional ability and quality of life: What are the long-term effects of intensive interventions to lower blood pressure on cognitive function, functional ability and quality of life compared with standard interventions in people with acute intracerebral haemorrhage?

    haemorrhage. Source guidance details Comes from guidance Stroke and transient ischaemic attack in over 16s: diagnosis and initial...

    Research recommendation
    Published
    11 May 2022

  9. Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia (TA694)

    Evidence-based recommendations on bempedoic acid with ezetimibe (Nilemdo and Nustendi) for treating primary hypercholesterolaemia or mixed dyslipidaemia as an adjunct to diet in adults.

    Technology appraisal guidance
    Published
    28 April 2021
    View recommendations

    Sections for TA694

  10. TactiCath Quartz catheter for percutaneous radiofrequency ablation in atrial fibrillation (MIB60)

    NICE has developed a medtech innovation briefing (MIB) on the TactiCath Quartz catheter for percutaneous radiofrequency ablation in atrial fibrillation

    Medtech innovation briefing
    Published
    23 March 2016

  11. Percutaneous insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shock (HTG775)

    Evidence-based recommendations on percutaneous insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shock. This involves a small pump being inserted through the skin, through an artery and into the heart, to temporarily pump blood out of the heart and restore blood flow.

    HealthTech guidance
    Published
    25 March 2026

    Sections for HTG775

  12. Surgical insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shock (HTG774)

    Evidence-based recommendations on surgical insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shock. This involves a small pump being surgically inserted using a graft, through an artery and into the heart, to temporarily pump blood out of the heart and restore blood flow.

    HealthTech guidance
    Published
    25 March 2026

    Sections for HTG774

  13. Backing the healthtech that changes lives

    an implantable cardiac monitor to detect atrial fibrillation following a stroke, and a rapid genetic test that protects newborns from...

    News
    Last updated
    15 April 2026

  14. What is the safety and efficacy of botulinum toxin compared with (a) usual care, (b) antimuscarinics and (c) augmentation cystoplasty in people with primary cerebral conditions with lower urinary tract dysfunction?

    people with primary cerebral conditions including (but not restricted to) stroke, head injury and cerebral palsy, but excluding multiple...

    Research recommendation
    Published
    9 June 2015

  15. Tools for case identification for cognitive impairment in criminal justice system populations:- What are the reliable and valid tools to identify cognitive impairment among people in contact with the criminal justice system (including people who have experienced physical trauma, neurodevelopmental disorders or other acquired cognitive impairment)?

    impairment may arise as a result of, for example, traumatic brain injury, a stroke or other neurological conditions. Experts in this...

    Research recommendation
    Published
    16 May 2017